“Why is the death rate about 75 percent lower in many countries?” asked Dr. Jane Orient, executive director of the Association of American Physicians and Surgeons, in reference to a recent analysis that shows a large gap in Covid19 death rates between countries that prescribe Hydroxychloroquine and countries that do not.
“The COVID-19 pandemic struck America nine months before a presidential election, turning basic medical activities like testing and treatment into partisan battlegrounds,” Economic Standard Editor-in-Chief Erik Sass writes in a recently published white paper on the subject.
“No subject has been more distorted than hydroxychloroquine (HCQ), a safe, versatile medicine that has treated hundreds of millions of people for numerous diseases for seven decades.”
There has been a concerted effort to delegitimize the use of Hydroxychloroquine since President Trump mentioned its potential in treating Covid19 in March.
“The U.S. is an international outlier on HCQ,” Sass adds. “Right now, doctors around the world are prescribing HCQ to treat COVID-19 outside of hospitals, as well as prophylactically to prevent infection among healthcare workers and vulnerable populations.”